BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36175445)

  • 1. Elite controllers long-term non progressors present improved survival and slower disease progression.
    Capa L; Ayala-Suárez R; De La Torre Tarazona HE; González-García J; Del Romero J; Alcamí J; Díez-Fuertes F
    Sci Rep; 2022 Sep; 12(1):16356. PubMed ID: 36175445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A follow-up study of HIV long-term non-progress populations in Henan province].
    Xue X; Sun G; Liu C; Liu J; Tian S; Wang Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Aug; 48(8):684-7. PubMed ID: 25388463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different immunological phenotypes associated with preserved CD4+ T cell counts in HIV-infected controllers and viremic long term non-progressors.
    Gaardbo JC; Hartling HJ; Ronit A; Thorsteinsson K; Madsen HO; Springborg K; Gjerdrum LM; Birch C; Laye M; Ullum H; Andersen ÅB; Nielsen SD
    PLoS One; 2013; 8(5):e63744. PubMed ID: 23696852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are long-term non-progressors very slow progressors? Insights from the Chelsea and Westminster HIV cohort, 1988-2010.
    Mandalia S; Westrop SJ; Beck EJ; Nelson M; Gazzard BG; Imami N
    PLoS One; 2012; 7(2):e29844. PubMed ID: 22363409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV.
    Grabar S; Selinger-Leneman H; Abgrall S; Pialoux G; Weiss L; Costagliola D
    AIDS; 2009 Jun; 23(9):1163-9. PubMed ID: 19444075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of HIV-1 dual infection in long-term nonprogressor-elite controllers.
    Pernas M; Casado C; Sandonis V; Arcones C; Rodríguez C; Ruiz-Mateos E; Ramírez de Arellano E; Rallón N; Del Val M; Grau E; López-Vazquez M; Leal M; Del Romero J; López Galíndez C
    J Acquir Immune Defic Syndr; 2013 Nov; 64(3):225-31. PubMed ID: 23714744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naïve CD4
    Xu L; Liu Y; Song X; Li Y; Han Y; Zhu T; Cao W; Li T
    BMC Immunol; 2021 Jun; 22(1):36. PubMed ID: 34082709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
    Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS
    Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rates of long-term progression in HIV-1-positive elite controllers.
    Borrell M; Fernández I; Etcheverrry F; Ugarte A; Plana M; Leal L; García F
    J Int AIDS Soc; 2021 Feb; 24(2):e25675. PubMed ID: 33619912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral Characteristics Associated with the Clinical Nonprogressor Phenotype Are Inherited by Viruses from a Cluster of HIV-1 Elite Controllers.
    Casado C; Marrero-Hernández S; Márquez-Arce D; Pernas M; Marfil S; Borràs-Grañana F; Olivares I; Cabrera-Rodríguez R; Valera MS; de Armas-Rillo L; Lemey P; Blanco J; Valenzuela-Fernández A; Lopez-Galíndez C
    mBio; 2018 Apr; 9(2):. PubMed ID: 29636433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An examination of signs of disease progression in survivors of the Sydney Blood Bank Cohort (SBBC).
    Birch MR; Learmont JC; Dyer WB; Deacon NJ; Zaunders JJ; Saksena N; Cunningham AL; Mills J; Sullivan JS
    J Clin Virol; 2001 Oct; 22(3):263-70. PubMed ID: 11564591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elite controllers and lessons learned for HIV-1 cure.
    Lopez-Galindez C; Pernas M; Casado C; Olivares I; Lorenzo-Redondo R
    Curr Opin Virol; 2019 Oct; 38():31-36. PubMed ID: 31252326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients.
    Ramírez de Arellano E; Díez-Fuertes F; Aguilar F; de la Torre Tarazona HE; Sánchez-Lara S; Lao Y; Vicario JL; García F; González-Garcia J; Pulido F; Gutierrez-Rodero F; Moreno S; Iribarren JA; Viciana P; Vilches C; Ramos M; Capa L; Alcamí J; Del Val M
    PLoS One; 2019; 14(8):e0220459. PubMed ID: 31393887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insight in miRNome of Long-Term Non-Progressors and Elite Controllers Exposes Potential RNAi Role in Restraining HIV-1 Infection.
    Ayala-Suárez R; Díez-Fuertes F; Calonge E; De La Torre Tarazona HE; Gracia-Ruíz de Alda M; Capa L; Alcamí J
    J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32751854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.
    Dominguez-Molina B; Tarancon-Diez L; Hua S; Abad-Molina C; Rodriguez-Gallego E; Machmach K; Vidal F; Tural C; Moreno S; Goñi JM; Ramírez de Arellano E; Del Val M; Gonzalez-Escribano MF; Del Romero J; Rodriguez C; Capa L; Viciana P; Alcamí J; Yu XG; Walker BD; Leal M; Lichterfeld M; Ruiz-Mateos E;
    Clin Infect Dis; 2017 Mar; 64(5):621-628. PubMed ID: 27986689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocyte Based Correlates of Immune Activation and Viremia in HIV-Infected Long-Term Non-Progressors.
    Prabhu VM; Singh AK; Padwal V; Nagar V; Patil P; Patel V
    Front Immunol; 2019; 10():2849. PubMed ID: 31867010
    [No Abstract]   [Full Text] [Related]  

  • 17. Host Factor Predictors in Long-term Nonprogressors HIV-1 Infected with Distinct Viral Clades.
    Dos Santos JS; de Almeida SM; Ferreira GS; Bordignon J; Maia Teixeira SL; Martins Lima AC; Raboni SM
    Curr HIV Res; 2017; 15(6):440-447. PubMed ID: 29210660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in disease progression in a cohort of long-term non-progressors after more than 16 years of HIV-1 infection.
    Rodés B; Toro C; Paxinos E; Poveda E; Martinez-Padial M; Benito JM; Jimenez V; Wrin T; Bassani S; Soriano V
    AIDS; 2004 May; 18(8):1109-16. PubMed ID: 15166526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristics of long-term non-progressors and HIV controllers among HIV-infections in Henan, China].
    Liu J; Fan PY; Xue XJ; Sun DY; Sun GQ; Liu CH; Tian SA; Li N; Zhu Q; Wang Z
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Feb; 37(2):227-31. PubMed ID: 26917521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralizing antibodies are positively associated with CD4+ T-cell counts and T-cell function in long-term AIDS-free infection.
    Carotenuto P; Looij D; Keldermans L; de Wolf F; Goudsmit J
    AIDS; 1998 Sep; 12(13):1591-600. PubMed ID: 9764777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.